News about "Drugs Controller General of India "

India to Build Future-Ready Drug Regulatory Framework: J P Nadda

India will build a future-ready drug regulatory framework, with the Central Drugs Standard Control Organisation (CDSCO) set to launch an end-to-end digital regulatory platform within 18 months.

Drugs Controller General Of India | 01/08/2026 | By News Bureau

Glenmark Advances Global Phase 3 Trial of HER2-Targeted ADC for Platinum-Resistant Ovarian Cancer

Glenmark Specialty has initiated patient enrolment in India for the Phase 3 trial of trastuzumab rezetecan, aiming to expand treatment options for patients with platinum-resistant ovarian cancer across its licensed global markets.

Drugs Controller General Of India | 04/07/2026 | By News Bureau |  126

Akums Drugs and Pharmaceuticals Launches World's First Lasmiditan Dispersible Tablets for Acute Migraine Treatment

Akums Drugs and Pharmaceuticals introduces DCGI-approved Lasmiditan dispersible tablets, offering faster, patient-friendly migraine relief with improved compliance, especially for patients facing nausea and difficulty swallowing during acute attacks.

Drugs Controller General Of India | 18/03/2026 | By News Bureau |  170

ACC Extends Dr Rajeev Singh Raghuvanshi's appointment as Drugs Controller (India) for One Year

Dr Rajeev Singh Raghuvanshi receives a second one-year extension as head of CDSCO amid ongoing regulatory reforms and Schedule M implementation.

Drugs Controller General Of India | 02/03/2026 | By News Bureau |  961

Sun Pharma Wins DCGI Nod for Generic Semaglutide Injection

Sun Pharmaceutical has secured approval from the Drugs Controller General of India (DCGI) to manufacture and market a generic semaglutide injection for chronic weight management, paving the way for its entry into the fast-growing obesity treatment segment once the semaglutide patent expires in the country.

Drugs Controller General Of India | 27/01/2026 | By News Bureau |  282

Health Minister Highlights Expansion of Jan Aushadhi Kendras and AMRIT Pharmacies

Union Health Minister JP Nadda underscored the importance of expanding Jan Aushadhi Kendras and AMRIT pharmacies across the country, while emphasising the need for a robust drug regulatory framework that ensures quality, safety and compliance from manufacturing through last-mile distribution.

Drugs Controller General Of India | 03/01/2026 | By News Bureau |  293

No Physical Applications For WHO-GMP (COPP) Approvals After August 15: CDSCO

The Drugs Controller General of India has directed all zonal and sub-zonal offices of the Central Drugs Standard Control Organization (CDSCO) to stop accepting physical applications for WHO-GMP (Certificate of Pharmaceutical Product – COPP) after August 15, 2025.

Drugs Controller General Of India | 08/08/2025 | By Dineshwori |  923

Akums Becomes First Indian CDMO to Receive DCGI Approval for Innovative Glaucoma Treatment

Glaucoma ranks as the second leading cause of irreversible but preventable blindness worldwide, with India contributing to 23.5 percent of the global burden.

Drugs Controller General Of India | 01/04/2025 | By Abha |  613

CDSCO Launches Digital Portal to Simplify Extension Process for Pharma MSMEs

This initiative is integrated into the Online National Drugs Licensing System (ONDLS) and follows the Health Ministry's notification granting an extension for compliance with updated Good Manufacturing Practices (GMP).

Drugs Controller General Of India | 26/03/2025 | By Aishwarya |  509

Akums Combines Two Potent Diabetes Medicines for Enhanced Treatment Efficacy

Dapagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, aids in eliminating excess glucose via urine while delivering additional benefits such as improved cardiovascular and renal outcomes, along with better weight management.

Drugs Controller General Of India | 03/02/2025 | By Aishwarya |  709